Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Robin

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2009
First-year treatment costs among new initiators of topical prostaglandin analogsJordana K Schmier, David W Covert, Alan L Robin
Transactions of the American Ophthalmological Society|January 28, 2003
Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjectsMichael T Halpern, David W Covert, Alan L Robin
Current Medical Research and Opinion|February 24, 2009
First-year treatment patterns among new initiators of topical prostaglandin analogsJordana K Schmier, David W Covert, Alan L Robin
Current Medical Research and Opinion|November 4, 2010
First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008Jordana K Schmier, David W Covert, Alan L Robin
Indian Journal of Ophthalmology|December 1, 2022
Comments on: All India Ophthalmological Society (AIOS) Task Force guidelines to prevent intraocular infections and cluster outbreaks after cataract surgeryAakriti Garg Shukla, Alan L Robin, David F Chang
American Journal of Ophthalmology|October 23, 2025
Surgical Hand Antisepsis: How Can We Save Water?Amy Song, Margaret Tharp, Kira Wang, et al.
Expert Review of Ophthalmology|May 3, 2016
Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015Paula Anne Newman-Casey, Megan Dayno, Alan L Robin
Current Medical Research and Opinion|October 10, 2007
Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspectiveJordana K Schmier, David W Covert, Alan L Robin
Current Opinion in Ophthalmology|November 10, 2016
New classes of glaucoma medicationsEmily M Schehlein, Gary D Novack, Alan L Robin
The Ocular Surface|September 17, 2022
Redefining ocular drug deliveryAllisa J Song, Jennifer S Steger, Alan L Robin
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2009
First-year treatment costs among new initiators of topical prostaglandin analogsJordana K Schmier, David W Covert, Alan L Robin
Transactions of the American Ophthalmological Society|January 28, 2003
Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjectsMichael T Halpern, David W Covert, Alan L Robin
Current Medical Research and Opinion|February 24, 2009
First-year treatment patterns among new initiators of topical prostaglandin analogsJordana K Schmier, David W Covert, Alan L Robin
Current Medical Research and Opinion|November 4, 2010
First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008Jordana K Schmier, David W Covert, Alan L Robin
Indian Journal of Ophthalmology|December 1, 2022
Comments on: All India Ophthalmological Society (AIOS) Task Force guidelines to prevent intraocular infections and cluster outbreaks after cataract surgeryAakriti Garg Shukla, Alan L Robin, David F Chang
American Journal of Ophthalmology|October 23, 2025
Surgical Hand Antisepsis: How Can We Save Water?Amy Song, Margaret Tharp, Kira Wang, et al.
Expert Review of Ophthalmology|May 3, 2016
Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015Paula Anne Newman-Casey, Megan Dayno, Alan L Robin
Current Medical Research and Opinion|October 10, 2007
Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspectiveJordana K Schmier, David W Covert, Alan L Robin
Current Opinion in Ophthalmology|November 10, 2016
New classes of glaucoma medicationsEmily M Schehlein, Gary D Novack, Alan L Robin
The Ocular Surface|September 17, 2022
Redefining ocular drug deliveryAllisa J Song, Jennifer S Steger, Alan L Robin
Pageof 16